Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Westermann
A Aicher
A Pezzutto

Showing results (1-10 of 428) with videos related to

Pageof 43
Sort By:
Gene Therapy|May 14, 1998
Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activationJ Westermann, A Aicher, Z Qin, et al.
Experimental Hematology|January 1, 1997
Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cellsA Aicher, J Westermann, S Cayeux, et al.
The Journal of Biological Chemistry|September 26, 2001
Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cellsG Richter, M Hayden-Ledbetter, M Irgang, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Dendritic cells prevent CD95 mediated T lymphocyte death through costimulatory signalsP T Daniel, C Scholz, J Westermann, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2001
Granulocyte/macrophage-colony-stimulating-factor plus interleukin-2 plus interferon alpha in the treatment of metastatic renal cell carcinoma: a pilot studyJ Westermann, G Reich, J Kopp, et al.
Experimental Hematology|September 10, 1999
CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanismP T Daniel, C Scholz, F Essmann, et al.
Cancer Gene Therapy|April 9, 2016
CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor modelT Nguyen-Hoai, M Pham-Duc, M Gries, et al.
European Journal of Immunology|July 1, 1997
Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiencyS Cayeux, G Richter, C Becker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 1999
Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cellsA Aicher, G L Shu, D Magaletti, et al.
Bone Marrow Transplantation|August 10, 2000
Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemiaJ Westermann, J Kopp, I Körner, et al.
Pageof 43

Showing results (1-10 of 428) with videos related to

Sort By:
Pageof 43
Gene Therapy|May 14, 1998
Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activationJ Westermann, A Aicher, Z Qin, et al.
Experimental Hematology|January 1, 1997
Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cellsA Aicher, J Westermann, S Cayeux, et al.
The Journal of Biological Chemistry|September 26, 2001
Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cellsG Richter, M Hayden-Ledbetter, M Irgang, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Dendritic cells prevent CD95 mediated T lymphocyte death through costimulatory signalsP T Daniel, C Scholz, J Westermann, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2001
Granulocyte/macrophage-colony-stimulating-factor plus interleukin-2 plus interferon alpha in the treatment of metastatic renal cell carcinoma: a pilot studyJ Westermann, G Reich, J Kopp, et al.
Experimental Hematology|September 10, 1999
CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanismP T Daniel, C Scholz, F Essmann, et al.
Cancer Gene Therapy|April 9, 2016
CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor modelT Nguyen-Hoai, M Pham-Duc, M Gries, et al.
European Journal of Immunology|July 1, 1997
Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiencyS Cayeux, G Richter, C Becker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 1999
Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cellsA Aicher, G L Shu, D Magaletti, et al.
Bone Marrow Transplantation|August 10, 2000
Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemiaJ Westermann, J Kopp, I Körner, et al.
Pageof 43